5.750USD-1.54%Mkt Cap: 551.02M $P/E: —1d ago
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragme…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
Key Statistics
Company
Market Cap551.02M $
Enterprise Value345.88M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-68.65M $
Revenue/Share—
Last Price5.750 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees40
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-9.86
PEG—
EV/EBITDA-3.73
EV/Revenue—
P/S—
P/B2.78
EPS (TTM)-1.10
EPS (Forward)-0.58
52W Range
5.54044% of range6.020
52W High6.020 USD
52W Low5.540 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-67.61%
ROA-60.25%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-64.81M $
CapEx (TTM)113.00K $
FCF Margin—
FCF Yield-8.86%
Net Debt-205.13M $
Net Debt/EBITDA2.21
Balance Sheet
Debt/Equity—
Current Ratio12.90
Quick Ratio12.57
Book Value/Sh2.065 USD
Cash/Share2.141 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.1 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)18.00 USD
Upside (mean)+213.0%
Target Range11.00 USD – 26.00 USD
$11.00+213.0% to mean$26.00
# Analysts6
Ownership
Shares Out.95.83M
Float51.20M
Insiders18.92%
Institutions87.84%
Short Interest
Short Ratio11.9d
Short % Float14.74%
Short % Out.11.02%
Shares Short10.51M
Short (prev mo.)9.24M
Technical
SMA 505.129 (+12.1%)
SMA 2005.132 (+12.0%)
Beta-0.03
S&P 52W Chg18.16%
Avg Vol (30d)762.29K
Avg Vol (10d)968.02K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—